Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study ; day:22 ; month:6 ; year:2021 ; pages:1-8
Investigational new drugs ; (22.6.2021), 1-8
- Urheber
-
Tian, Zhichao
Wang, Jiaqiang
Yang, Jinpo
Zhang, Peng
Wang, Xin
Zhang, Fan
Li, Po
Yao, Weitao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-021-01139-w
- URN
-
urn:nbn:de:101:1-2021100907174074673423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tian, Zhichao
- Wang, Jiaqiang
- Yang, Jinpo
- Zhang, Peng
- Wang, Xin
- Zhang, Fan
- Li, Po
- Yao, Weitao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas – a single center experience
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
Metabolic landscapes in sarcomas
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas – a single center experience
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
Metabolic landscapes in sarcomas
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas – a single center experience
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas
Metabolic landscapes in sarcomas
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities